The total protein expression of SLC31A1 was found to be upregulated in GBM and downregulated in LIHC, per the Clinical Proteomic Tumour Analysis Consortium (CPTAC)6 dataset from the National Cancer Institute (Fig. 1C). This evidence concerns the gene SLC31A1 and neoplasm.